Merck KGaA, Darmstadt, Germany, to Acquire SpringWorks Therapeutics to Drive Sustainable Growth in Healthcare Portfolio
Merck KGaA, Darmstadt, Germany, to Acquire SpringWorks Therapeutics in Strategic Move to Accelerate Healthcare Growth Merck KGaA, Darmstadt, Germany (DAX: MRK), a global leader in science and technology, today announced that it has entered into a definitive agreement to acquire…
EyeCare Partners Showcases Latest Eye Care Innovations at ASCRS 2025 in Los Angeles
EyeCare Partners Showcases Latest Eye Care Innovations at ASCRS 2025 in Los Angeles EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, is set to make a powerful impact at the 2025 annual meeting of the American…
Metrion Biosciences Unveils Nav1.9 High-Throughput Screening Assay to Expand Pain Research and Enhance Screening Capabilities
Metrion Biosciences Launches High-Throughput NaV1.9 Screening Assay to Accelerate Non-Opioid Pain Therapeutics Research Metrion Biosciences (“Metrion”), a leading specialist preclinical contract research organisation (CRO) and globally recognised expert in ion channel research services, today announced the launch of its newly…
eClinicalWorks & Sunoh.ai: Deeper Patient Interactions in Behavioral Health
eClinicalWorks & Sunoh.ai: Deeper Patient Interactions in Behavioral Health Health Opportunities for the People of East Texas (HOPE), a leading Federally Qualified Health Center (FQHC), has successfully implemented Sunoh.ai, an innovative AI-powered medical scribe seamlessly integrated with the eClinicalWorks® cloud-based…
GE HealthCare at SBI 2025: Advancing Breast Cancer Imaging
GE HealthCare at SBI 2025: Advancing Breast Cancer Imaging GE HealthCare, a global frontrunner in breast health technology, is set to showcase its latest suite of advancements in diagnostic accuracy and patient-centric breast care at the 2025 Society of Breast…
South Australia Launches Sunrise EHR Statewide in All Public Hospitals
South Australia Launches Sunrise EHR Statewide in All Public Hospitals South Australia has etched its name in Australian healthcare history, becoming the first state to successfully implement a unified electronic health record (EHR) and patient administration system (PAS) across its…
CareDx to Present 60 Abstracts, 19 Oral, at 2025 ISHLT Meeting
CareDx to Present 60 Abstracts, 19 Oral, at 2025 ISHLT Meeting CareDx, Inc. (Nasdaq: CDNA), known as The Transplant Company™, has announced it will present 60 abstracts—including 19 oral presentations—at the 45th Annual Meeting & Scientific Sessions of the International…
Vizient Reviews Ortho Innovations and IV Fluid Conservation
Vizient Reviews Ortho Innovations and IV Fluid Conservation Vizient, Inc., the nation’s leading provider-driven healthcare performance improvement company, has released the latest edition of its Medical Device Tech Watch, spotlighting advancements in orthopedic technology, strategies for conserving intravenous (IV) fluids,…
Centauri Health Acquires MedAllies to Expand Data Network
Centauri Health Acquires MedAllies to Expand Data Network Centauri Health Solutions, a health IT company based in Phoenix, Arizona, has acquired MedAllies, a New York-based Health Information Service Provider (HISP) and Qualified Health Information Network® (QHIN™). MedAllies specializes in health…
PCI Pharma to Acquire Ajinomoto Althea
PCI Pharma to Acquire Ajinomoto Althea PCI Pharma Services (PCI), a global leader in contract development and manufacturing (CDMO) focused on biopharmaceutical innovation, has announced the acquisition of Ajinomoto Althea, Inc. (Althea), a US-based sterile fill-finish CDMO. Althea is currently…
Health Future Awards Henry Schein Supplier Agreement for Disposable Skin Stapler and Remover
Health Future Awards Henry Schein Supplier Agreement for Disposable Skin Stapler and Remover Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, has announced a new partnership with Health Future, a…
Novocure’s Optune Lua® Gets CE Mark for mNSCLC Treatment
Novocure’s Optune Lua® Gets CE Mark for mNSCLC Treatment Novocure (NASDAQ: NVCR) has announced that its Optune Lua® device has received the CE Mark (Conformité Européenne) for treating adult patients with metastatic non-small cell lung cancer (mNSCLC) who are undergoing…